A detailed history of Zeke Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 9,793 shares of ZTS stock, worth $1.61 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
9,793
Previous 7,881 24.26%
Holding current value
$1.61 Million
Previous $1.17 Million 22.86%
% of portfolio
0.09%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $250,739 - $301,082
1,912 Added 24.26%
9,793 $1.44 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $1,779 - $2,190
-12 Reduced 0.15%
7,881 $1.17 Million
Q2 2022

Aug 09, 2022

SELL
$155.97 - $200.09 $1.57 Million - $2.02 Million
-10,074 Reduced 56.07%
7,893 $1.36 Million
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $3.26 Million - $4.2 Million
17,967 New
17,967 $3.39 Million
Q1 2020

Apr 24, 2020

SELL
$92.66 - $144.94 $794,559 - $1.24 Million
-8,575 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$116.25 - $133.25 $28,248 - $32,379
-243 Reduced 2.76%
8,575 $1.14 Million
Q3 2019

Oct 18, 2019

BUY
$112.57 - $128.43 $16,210 - $18,493
144 Added 1.66%
8,818 $1.1 Million
Q1 2019

Apr 29, 2019

SELL
$81.56 - $100.67 $9,705 - $11,979
-119 Reduced 1.35%
8,674 $873,000
Q4 2018

Feb 11, 2019

SELL
$79.28 - $95.27 $28,461 - $34,201
-359 Reduced 3.92%
8,793 $752,000
Q2 2018

Jul 24, 2018

SELL
$79.9 - $89.2 $155,085 - $173,137
-1,941 Reduced 17.5%
9,152 $780,000
Q1 2018

May 03, 2018

BUY
$71.51 - $84.69 $138,800 - $164,383
1,941 Added 21.21%
11,093 $926,000
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $34,971 - $40,258
553 Added 6.43%
9,152 $659,000
Q3 2017

Nov 09, 2017

BUY
$59.73 - $65.4 $513,618 - $562,374
8,599
8,599 $548,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.